Method of treating cancer

Details Method of treating cancer Method of treating cancer

Filed on

1997-02-06

Date issued

2000-07-18

Examiner

Minnifield, Nita

Patent Class

Drug, bio-affecting and body treating compositions

SubClass

Antigen, epitope, or other immunospecific immunoeffector

Other Related Categories

4242781, 424513, 424520, 42419711, A61K 3900, A61K 3938, A61K 4500, A61K 3512

Type

Patent

Status

active

Patent number

060903856

Description

ABSTRACT:
A method of treating cancers by administering to a patient an anti-tumor effective amount ot at least one of a thermostable macromolecular antigen complex or a fragment of such a complex which is interspecific for microorganisms of the Mycobacteria, Nocardia and Corynebacteria group and which exhibits after immunoelectrophoresis an immunoelectrophoretic precipitation pattern corresponding to that of the antigen complex 60 of Mycobacteria bovis Calmette Guerin Bacillus strain. Preferably, the patient is also treated with an additional therapeutic agent which is specific against the patient's cancer such as a tumoral antigen or a non-proliferative tumor cell.

REFERENCES:
patent: 4504473 (1985-03-01), Cantrell
patent: 4505903 (1985-03-01), Cantrell
patent: 4543253 (1985-09-01), Yamamura et al.
patent: 4613504 (1986-09-01), Cantrell
patent: 4663306 (1987-05-01), Cantrell
patent: 4726947 (1988-02-01), Shimada et al.
patent: 4777130 (1988-10-01), Maes
patent: 4965192 (1990-10-01), Maes
patent: 5091308 (1992-02-01), Klegerman et sl.
patent: 5484596 (1996-01-01), Hanna et al.
Maes, Klin. Wochenschr, 69:696-709, 1991.
Maes et al, Scand. J. Immunol. 41:53-64, 1995.
Closs et la. Scand. J. Immunol. 12:249-63, 1980.
Pines, Lancet, Feb. 21, 1976 pp. 380-381, 1976.
Beaudet et al, Ann. Immunol. 134 C: 216-26, 1983.
Hanna et al, J. Nat'l Cancer Inst. 51:1897-1908, 1973.
Encyclopedia of Biochemistry Ed. Williams & Lansford pp. 735-736, pp. 589-91, 1967.
Lou et al, Anticancer Research, 14: 1469-1476, 1994.
Cocito et al. Med. Microbiol Immunol. 177: 357-367, 1988.
Lomakin et al, Byulleten' Eksperimental 'noi Biologii i Meditsiny 83/1: 65-68, Jan. 1977.
Merck Manual, Home Edition p. 887, 1997.
Cocito et al, Clin. Exp. Immunol, 66:262-272, 1986.
Wainberg et al, Br. J. Cancer, 34: 500-508, 1976.
Pinsky et al, Natl Cancer Inst. Monogr. 39: 225-228, 1973.
Mathe et al, Natl Cancer Inst. Monogr. 39: 165-175, 1973.
Gueur et al, Scand. J. Immunol. 17: 497-506, 1983.
Immunobiology for the Clinician Ed: Barber. p. 241, 1977.
Dunlap et al, Tuberculosis, 77/6: 1235-1251, 1993.
Bennett et al, Cancer Research 43: 4183-4190, 1983.
McKneally et al Lancet May 7, 1977 p. 1003, 1977.
Coltsier et al, Clin. & Diagnost.Lab.Immunol. 1/2: 139-144, 1994.
Duda et al Cancer Researcher Weekly May 2, 1994 Abstract Only, 1994.
Morales et al. J. Urology, 116: 180-183, 1976.
Codish et al. J. Surgical Oncology 10: 447-455, 1978.
Parr, Cancer Immunol. Immunother. 1:51-53, 1976.
Sparks et al. New Eng. J. Med. 289:287-830, 1973.
Baldwin et al. Ann. N.Y. Acad. Sciences 277: 124-134, 1976.
Nathanson, Seminars in Oncology 1/4: 337-350, 1974.
Bruneteau et al. 1992. Composition and Immunogenicity of the Polysaccharide Components . . . Med. Microbiol, Immunol. 181. 13-23.
Hubbard et al. 1992. Immunization of Mice with the Antigen A6D of Mycobacteruim boris BCG. Clin. Exp. Immunol. 88: 129-131.
Yasumoto et al. 1979. Nonspecific Adjuvent Immunotherapy of Lung Cancer . . . Cancer Res. 39: 3262-67.
Beschin et al. 1991. Mycobacterial Proliferation in Macrophage is Prevented . . . Eur. J.Immunol. 21: 793-797.
Benoit et al. 1989 Delayed Hypersensitivity Reactions by the Mycobacterial Antigen A6O . . . Med Microbiol Immunol.178: 105-112.
Cocito et al. 1991. Properties of the Mycobacterial Antigen Complex A6O and its Applications . . . Chest. 100(6): 1687-1693.
Yamamura et al. 1978. Mycobacteria and Cellular Immunity. Tuberculosis (Tokyo) 53/11 :551-554 Abstract only.
Carlucci, et al. 1993. Mycobacterial Antigen A6O-Specific T-Cell Reperrtorie . . . Infection and Immunity.61(2):439-447.
Groves, 1993. Pharmaceutical Characterization of Mycobacleruim boris . . . J. Pharmaceutical Sciences. 82(6): 555-562.2.
Abou-Zeid et al. 1985, Cross-Reactivity of Antigens from the Cytoplasm and Cell Walls . . . J. Infectious Dis. 151(1): 170-178.
Pang et al. 1982 Immunioprophylaxis of a Murine Bladder Cancer with High . . . J. of Urology. 127(5): 1006-1009.
Yamamura et al. 1976. Immunotherapy of Cancer with Cell Wall Skeleton . . . Ann. N.Y. Acad. Sci. 277: 209-227.
Kaplan et al. 1980. Cancer 46: 2195-2202.

Affiliated with

Also associated with

Rating

Method of treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2033706